ASRM

I-ASRM ishicilela imininingo yezokwelapha ye-Conceive Plus

0 amazwana

Siyaqhenya ngezifundo eziningi esizenzile ukuqinisekisa ubunjalo obuyingqayizivele be-Conceive Plus. Ngo-Okthoba 2009 izifundo zethu zethulwa e 2009 Annual Meeting of the American Society for Reproductive Medicine. Chofoza ukuze ubuke izifundo ezishicilelwe I-Conceive Plus® yagunyazwa njengephephile ukuthi isetshenziswe ngabalingani abazama ukukhulelwa yi-Food and Drug Administration (FDA) ngomhlaka 7 Novemba 2013 ngaphansi kwe-510(k): K131355. I-Conceive Plus® iyavumelana nesidoda somuntu, ama-oocyte nama-embryo futhi iphephile ukusetshenziswa ngabalingani abazama ukukhulelwa.

Ikhodi yomkhiqizo: PEB (lubricant, personal, gamete, fertilization, and embryo compatible) Class II (21 CFR 884.5300)

AMACEBISO OKUKHULELWA OKUZOKUSIZA UKUTHI UKHONDE

Isikhathi sokuqala ukusebenza ukuze ube nokukhulelwa okunempilo singesikhathi ngaphambi kokuthi ukhulelwe. Uma uzama ukukhulelwa amacebiso ethu okukhulelwa ayisiqalo esihle sokulungiselela umzimba wakho ukukhulelwa. Funda okuningi lapha

OKUNINGI NGENGE-CONCEIVE PLUS

Uma usanda kuqala ukuzama ukukhulelwa noma usuvele uzame isikhathi esithile, Conceive Plus® ingasiza ukwandisa amathuba akho okukhulelwa ngokwemvelo! Iyanconywa odokotela, osokhemisi nezikhungo zokuzala emazweni angaphezu kuka-60, lokhu kuyilubricant elinobungane ekuzaleni eligunyazwe yi-FDA futhi awudingi iresiphi kadokotela.
Yabelana

Ukuze uthole imiphumela emihle!

Londoloza u-10% futhi uthole izincomo zemikhiqizo yokuzala ngqo ebhokisini lakho lokungenayo le-imeyili.

Uzama ukukhulelwa?

Qala Ukusebenzisa i-Conceive Plus Namuhla!

Kutholakala futhi ku